北摩高科(002985) - 2024 Q4 - 年度业绩预告

Financial Performance Expectations - The company expects a net profit attributable to shareholders of between RMB 15 million and RMB 22 million for 2024, representing a decline of 89.88% to 93.10% compared to RMB 217.43 million in the previous year[3]. - The net profit after deducting non-recurring gains and losses is projected to be between RMB 5.47 million and RMB 12.47 million, down 94.03% to 97.38% from RMB 208.95 million last year[3]. - Basic earnings per share are estimated to be between RMB 0.05 and RMB 0.07, a significant decrease from RMB 0.66 per share in the previous year[3]. Revenue and Profitability Challenges - The decline in revenue is attributed to delays in contract signing and pricing, which affected the recognition of income during the reporting period[6]. - The product mix has shifted, with a higher proportion of lower-margin products impacting overall profitability[6]. - The company is experiencing slower collection of accounts receivable due to industry factors, despite improved collections in the fourth quarter[6]. Financial Reporting - The preliminary financial data provided is subject to change and will be finalized in the 2024 annual report[7].